Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EML4 | Q9HC35 | 1/20 | 0.43 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 9/20 | 0.40 |
| ▸ | NOTUM | Q6P988 | 3/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.38 |
| ▸ | JAK3 | P52333 | 1/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1749219 | 0.86 | ALDH1A1 (0.45) | GAANOTUMMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL1749216 | 0.86 | ALDH1A1 (0.45) | GAANOTUMMAPTSMN1; SMN2ALDH1A1 | |
| SCHEMBL274575 | 0.85 | EML4 (0.47) | EML4ALKGAAHSD11B1TP53 | |
| SCHEMBL17135166 | 0.85 | EML4 (0.47) | EML4ALKGAAHSD11B1TP53 | |
| SCHEMBL1749402 | 0.84 | GAA (0.47) | GAAMAPTALDH1A1HTTKDM4E | |
| SCHEMBL1749232 | 0.83 | GAA (0.41) | GAANOTUMMAPTALDH1A1HTT | |
| SCHEMBL2171157 | 0.81 | ALDH1A1 (0.41) | GAAALDH1A1HTTNR4A1 | |
| SCHEMBL1750586 | 0.81 | GAA (0.43) | GAAMAPTJAK3KDM4EHSD17B10 | |
| SCHEMBL1749278 | 0.81 | GAA (0.40) | GAANOTUMMAPTALDH1A1HTT | |
| SCHEMBL20374353 | 0.80 | ALDH1A1 (0.49) | EML4ALKGAAHSD11B1NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040220191-A1 | Substituted N-aryl heterocycles, process for their preparation and their use as medicaments | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040220191-A1 | Substituted N-aryl heterocycles, process for their preparation and their use as medicaments | CYP11B2, CYP11B1, CYP1A1 | EML4 2557/4885ALK 2479/4885GAA 1379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.